Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine

Psychopharmacology

Volumn 150, Issue 1, 2000, Pages 120-122

  Whale, R ^a   Quested, D J ^a   Laver, D ^a   Harrison, P J ^a   Cowen, P J ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

5 HT transporter; 5 Hydroxytryptamine; Antidepressant; Brain 5 HT function; Polymorphism

Indexed keywords

CLOMIPRAMINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; GENOTYPE; HUMAN; PRIORITY JOURNAL; PROMOTER REGION; SEROTONIN RELEASE; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; CARRIER PROTEINS; CLOMIPRAMINE; FEMALE; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; PROLACTIN; PROMOTER REGIONS (GENETICS); SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 0034123412     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000432     Document Type: Article

References (13)

1. Adell A, Artigas F (1991) Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study. Naunyn Schmiedeberg's Arch Pharmacol 343:237-244
2. Anderson IM, Ware CJ, da Roza Davis JM, Cowen PJ (1992) Decreased 5-HT-mediated prolactin release in major depression. Br J Psychiatry 160:372-378
3. Bel N, Artigas F (1992) Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol 229:101-103
4. Collier DA, Stöber G, Li T, Heils A, Catalano M, Di Bella D, Arranz MJ, Murray RM, Vallada HP, Bengel D, Müller CR, Roberts GW, Smeraldi E, Kirov G, Sham P, Lesch KP (1996) A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1:453-460
5. Cowen PJ (1993) Serotonin receptor subtypes in depression: evidence from studies in neuroendocrine regulation. Clin Neuropharmacol 16(Suppl 3):S6-S18
6. Edwards JG, Anderson I (1999) Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs 57:507-533
7. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br J Pharmacol 115:1064-1070
8. Greenberg BD, Tolliver TJ, Huang S-J, Li Q, Bengel D, Murphy DL (1999) Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88:83-87
9. Heils A, Teufel A, Petri S, Seemann M, Bengel D, Balling U, Riederer P, Lesch KP (1995) Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. J Neural Transm 102:247-254
10. Klauck SM, Poustka F, Benner A, Lesch KP, Poustka A (1997) Serotonin transporter (5-HTT) gene variants associated with autism? Hum Mol Genet 6:2233-2238
11. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531
12. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR, Del Proposto ZS, Hill E, Cassin BJ, Watson SJ, Cook EH (1998) Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 155:207-213
13. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M (1998) Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3:508-511